At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 45 enrolled
Drug / intervention
botulinum toxin Type Abiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
In Brief
A Phase 4 clinical trial evaluating botulinum toxin Type A for Skin Aging. Completed, enrolled 45 participants across 2 sites.
Detailed Summary
This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Aging
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedMar 2009
Primary CompletionApr 2009
TodayJul 2026
First PostedMar 5, 2009
Enrollment StartMar 1, 2009
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.3 years ago
Interventions
botulinum toxin Type Abiological
20U, up to two injections administered intramuscularly into the glabella (2 in each side of the corrugators and 1 in the procerus)